Clinical Trial Update: Cisplatin Plus Temozolomide Compared With Temozolomide in Patients With MGMT Promotor Unmethylated Glioblastoma [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial comparing cisplatin plus temozolomide to temozolomide alone in MGMT promoter unmethylated glioblastoma is in Phase 1/2 with unclear current sta…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma

Drugs mentioned

• Cisplatin + Temozolomide
• Temozolomide (Temozolomide)

Snippet

Sponsor: Zhongnan Hospital | Conditions: Glioblastoma Multiforme of Brain | Phase 1, Phase 2 | Status: UNKNOWN